2.4% for placebo About 1 in 3 participants who adhered to treatment lost 20% or more of their body weight The injectable Wegovy 2.4 mg, by comparison, has shown approximately 14.9% average weight loss in trials, slightly higher than the pills average 13.6% result, though the difference narrows when comparing fully adherent populations
Each batch undergoes analytical testing, including HPLC and mass spectrometry, to confirm purity and identity
It has been shown that consumption of this supplement along with a healthy lifestyle helps to improve the rate of weight loss
First Affiliated Hospital Xian Jiaotong University
ElSayed NA, Aleppo G, Bannuru RR, Bruemmer D, Collins BS, Ekhlaspour L, et al
10.3390/molecules21030264 194 PurbadiS.RustamadjiP.PrijantiA